OGEN

Oragenics Inc

$1.10

-0.05 (-4.35%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 19.08.2025
$2.00
(+81.82%)
Strong Buy: 0
Buy: 0
Hold: 0
Sell: 0
Strong Sell: 0
Description:
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company is headquartered in Tampa, Florida.
Exchange:
NYSE MKT
Country:
USA
Sector:
LIFE SCIENCES
Industry:
PHARMACEUTICAL PREPARATIONS
Address:
4902 EISENHOWER BLVD, SUITE 125, TAMPA, FL, US
Fiscal year end:
December
Market capitalization:
$4.75 Million
EBITDA:
-$10.5 Million
PERatio:
0.0
EPS:
-19.06
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
0.652

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
-100%
How much will you get:
$0
Prices dates:
31-07-2015: $47,160.00 and 31-07-2025: $1.26